Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Syngene International Limited
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Registered Details

SYNGENE INTERNATIONAL LIMITED

All Companies ›

Karnataka ›

Health and Social Work ›

Active

Updated: 22 Nov 2025

The company contract research and manufacturing company. It provides integrated drug discovery and development services

Syngene International Limited, is a listed public company incorporated on 18 November, 1993. It is classified as a public limited company and is located in , Karnataka. It's authorized share capital is INR 500.00 cr and the total paid-up capital is INR 402.94 cr.

Subscription Plans

Industry and products

Health and Social Work

library and peptide synthesis, medicinal and synthetic chemistry, organic electronic materials, biomolecules, and computational and discovery analytical chemistry; and discovery biology services i

Company size

Auth Capital

₹ 500.0 Cr

Paidup Capital

₹ 402.9 Cr

Revenue

₹ 3250-3500 cr

Key Metrics

** All rupee values in INR crores.

Total Revenue

0.81%

₹ GET PRO

EBITDA

-5.95%

₹ GET PRO

Net Profit

-1.37%

₹ GET PRO

Networth

15.82%

₹ GET PRO

Borrowings

-75.37%

₹ GET PRO

Assets

-0.24%

₹ GET PRO

Gross Margin

-1.02

GET PRO %

Operating Margin

-1.83

GET PRO %

Net Profit Margin

-0.31

GET PRO %

Return on Equity

-1.94

GET PRO %

ROCE

-2.74

GET PRO %

Debt to Equity

-0.13

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
Financial+Litigation report

₹ 1299
- Everything in financial report
- Litigation report on the company
Due diligence report

₹ 2999
- Everything in financial+litigation report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.

Locations

India (11)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Director	Catherine Patricia Rosenberg Shareholder	06422834	25 years
Director	Sharmila Abhay Karve	05018751	6 years
Director	Kush M Parmar	09212020	4 years
Director	Vinita Bali	00032940	8 years
Director	Kiran Mazumdar Shaw Shareholder	00347229	32 years
Director	Suresh Narayanan	07246738	0 years
Director	Manja Hermina Elisabeth Maria Boerman	10655368	1 years
Director	Nilanjan Roy	02703775	2 years

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	400.0	400.0	400.8	401.4	402.0
Reserves	1,775.8	2,421.4	2,896.8	3,216.6	3,855.8
Borrowings +	308.9	772.3	789.6	575.3	141.7
Long term borrowings	-	512.4	531.5	489.0	100.0
Short term borrowings	308.9	259.9	258.1	86.3	41.7
Trade payables +	222.0	241.6	232.8	258.0	255.5
Days payable	156.0	167.0	113.0	109.0	100.0
Other liabilities +	1,678.2	1,289.5	1,476.6	1,637.7	1,752.1
Other non-current liabilities	447.9	416.4	505.8	535.8	649.6
Other current liabilities	1,008.3	631.5	738.0	843.9	847.0
Total liabilities	4,162.9	4,883.2	5,563.8	5,831.0	6,151.6
Fixed Assets +	2,253.8	2,438.2	2,739.2	2,843.7	3,688.1
Tangible assets	1,999.0	2,181.9	2,380.2	2,648.3	2,821.8
CWIP	234.1	237.2	346.4	176.9	838.1
Intangible assets	20.7	19.1	12.6	18.5	28.2
LT loans and advances	-	-	-	-	-
Other non-current assets	220.5	551.6	618.7	562.0	504.5
Current assets +	1,688.6	1,893.4	2,205.9	2,425.3	1,959.0
Inventories	25.2	59.6	179.4	332.8	238.5
Trade receivables	398.2	339.2	507.7	529.3	441.6
Cash and cash equivalents	193.0	323.3	261.8	89.5	85.7
ST loans and advances	-	-	-	-	-
Other current assets	1,072.2	1,171.3	1,257.0	1,473.7	1,193.2
Total assets	4,162.9	4,883.2	5,563.8	5,831.0	6,151.6

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	9.61	8.19	7.2	6.88	6.53
Reserves	42.66	49.59	52.07	55.16	62.68
Borrowings +	7.42	15.82	14.19	9.87	2.3
Long term borrowings	0.0	10.49	9.55	8.39	1.63
Short term borrowings	7.42	5.32	4.64	1.48	0.68
Trade payables	5.33	4.95	4.18	4.42	4.15
Other liabilities +	40.31	26.41	26.54	28.09	28.48
Other non-current liabilities	10.76	8.53	9.09	9.19	10.56
Other current liabilities	24.22	12.93	13.26	14.47	13.77
Total liabilities
Fixed Assets +	54.14	49.93	49.23	48.77	59.95
Tangible assets	48.02	44.68	42.78	45.42	45.87
CWIP	5.62	4.86	6.23	3.03	13.62
Intangible assets	0.5	0.39	0.23	0.32	0.46
LT loans and advances	0.0	0.0	0.0	0.0	0.0
Other non-current assets	5.3	11.3	11.12	9.64	8.2
Current assets +	40.56	38.77	39.65	41.59	31.85
Inventories	0.61	1.22	3.22	5.71	3.88
Trade receivables	9.57	6.95	9.13	9.08	7.18
Cash and cash equivalents	4.64	6.62	4.71	1.53	1.39
ST loans and advances	0.0	0.0	0.0	0.0	0.0
Other current assets	25.76	23.99	22.59	25.27	19.4
Total assets

Total assets

Charges on assets

Bank wise

Charges

Kotak Mahindra Bank Limited

No. of Loans: 1

Total Amount : 375.0 cr

Charge Holder	Amount	Date of creation/modification
Kotak Mahindra Bank Limited	375.0 cr	29 Oct, 2025

Charges

Kotak Mahindra Bank Limited

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
BAJAJ AUTO LIMITED.	Active	279.3 Cr	2	Maharashtra
BIOCON BIOPHARMACEUTICALS LIMITED	Amalgamated	17.6 Cr	1	Karnataka
CSEP RESEARCH FOUNDATION	Active	1.0 L	1	Delhi
BIOCON RESEARCH LIMITED	Active	5.0 L	1	Karnataka
SCIENCE GALLERY BENGALURU	Active	0.0	1	Karnataka
BIOFUSION THERAPEUTICS LIMITED	Active	5.0 L	1	Karnataka
GLENLOCH PROPERTIES LLP	Active	1.0 L	1	Karnataka
MAZUMDAR SHAW MEDICAL FOUNDATION	Active	1.0 L	1	Karnataka
KARNATAKA TECHNOLOGY AND INNOVATION MUSEUM FOUNDATION	Active	1.0 L	1
INNOVERSE FOUNDATION	Active	1.0 L	1
IMMUNEEL THERAPEUTICS PRIVATE LIMITED	Active	4.6 L	1	Karnataka
CLINIGENE INTERNATIONAL LIMITED	Amalgamated	5.0 L	1	Karnataka
BIOCON PHARMA LIMITED	Active	887.1 Cr	1	Karnataka
NARAYANA HRUDAYALAYA LIMITED	Active	204.4 Cr	1	Karnataka
TRENT LIMITED	Active	35.5 Cr	1	Maharashtra
BIOCON LIMITED	Active	668.5 Cr	1	Karnataka
BIOCON BIOSPHERE LIMITED	Active	631.4 Cr	2	Karnataka
BIOCON BIOLOGICS LIMITED	Active	1,758.3 Cr	1	Karnataka
BIOCON ACADEMY	Active	5.0 L	1	Karnataka
AUGERE WIRELESS BROADBAND INDIA PRIVATE LIMITED	Amalgamated	142.3 Cr	1	Delhi
AADHAR HOUSING FINANCE LIMITED	Active	426.5 Cr	1	Karnataka
CSB BANK LIMITED	Active	173.5 Cr	1	Kerala
THOMAS COOK (INDIA) LIMITED	Active	47.0 Cr	1	Maharashtra
VANAZ ENGINEERS LIMITED	Active	2.1 Cr	1	Maharashtra
TATA ELECTRONICS PRIVATE LIMITED	Active	7,202.9 Cr	1	Karnataka
EPL LIMITED	Active	64.0 Cr	1	Maharashtra
THE ADVERTISING STANDARDS COUNCIL OF INDIA	Active	0.0	1	Maharashtra
DR. REDDY'S AND NESTLE HEALTH SCIENCE LIMITED	Active	1,440.0 Cr	1	Telangana

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
Syngene USA Inc.	United States	-	-
SYNGENE SCIENTIFIC SOLUTIONS LIMITED		2022	₹ 84.0 Cr
SYNGENE MANUFACTURING SOLUTIONS LIMITED		2022	₹ 1.0 Cr

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

CIN

L85110KA1993PLC014937

PAN

AABCS9936M

Incorporation

1993, 32.0 years

Company Email

priyadarshini[dot]mahapatra[at]syngeneintl[dot]com

Paid up Capital

₹ 402.9 Cr

Authorised Capital

₹ 500.0 Cr

AGM

Jul 2025

Type

Public

Others

FAQ - SYNGENE INTERNATIONAL LIMITED

What is the incorporation date of SYNGENE INTERNATIONAL LIMITED?

The incorporation date of SYNGENE INTERNATIONAL LIMITED is 18 November, 1993

What is the authorized share capital of SYNGENE INTERNATIONAL LIMITED?

The authorized share capital of SYNGENE INTERNATIONAL LIMITED is INR ₹ 500.0 Cr.

What is the paid-up capital of SYNGENE INTERNATIONAL LIMITED?

The paid-up capital of SYNGENE INTERNATIONAL LIMITED is INR ₹ 402.9 Cr.

What is the registered address of SYNGENE INTERNATIONAL LIMITED?

The registered address of SYNGENE INTERNATIONAL LIMITED is Biocon SEZ, Biocon Park,Plot.No.2 & 3, Bommasandra Indst. Area IV Phase, Jigani Link Rd, Bo, mmasandra, Bangalore, Karnataka, India, 560099 - 560099

What is the CIN number of SYNGENE INTERNATIONAL LIMITED?

The CIN number of SYNGENE INTERNATIONAL LIMITED is L85110KA1993PLC014937.

Smart Suggestions

Top Blog Post

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

SYNGENE INTERNATIONAL LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Financial+Litigation report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Charges on assets

Charges

Company Network